Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Diabetes”

2,588 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,588 results

Large-scale testing (Phase 3)Study completedNCT01730534
What this trial is testing

Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events

Who this might be right for
Diabetes Mellitus, Non-Insulin-DependentHigh Risk for Cardiovascular Event
AstraZeneca 17,190
Not applicableStudy completedNCT00811317
What this trial is testing

Closed-loop Glucose Control for Automated Management of Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Boston University Charles River Campus 11
Large-scale testing (Phase 3)Study completedNCT00363233
What this trial is testing

The Potential Effects and Mechanisms of Flax Lignans on Type 2 Diabetes Mellitus

Who this might be right for
Type 2 DiabetesHypercholesterolemia
Chinese Academy of Sciences 80
Testing effectiveness (Phase 2)Study completedNCT01969747
What this trial is testing

Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days

Who this might be right for
Diabetes Mellitus, Type 1
Boehringer Ingelheim 75
Early research (Phase 1)Looking for participantsNCT07399678
What this trial is testing

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Who this might be right for
Overweight or Obese AdultsOverweight or Obese, Type 2 Diabetes
Alveus Therapeutics, Inc. 180
Post-approval studies (Phase 4)Ended earlyNCT00936663
What this trial is testing

Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation

Who this might be right for
Type 2 DiabetesEnd Stage Renal Disease
University of Nebraska 3
Early research (Phase 1)Study completedNCT01530048
What this trial is testing

Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL)

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 34
Testing effectiveness (Phase 2)Ended earlyNCT00982293
What this trial is testing

The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II Diabetes

Who this might be right for
Type 2 Diabetes
pico-tesla Magnetic Therapies, LLC 165
Large-scale testing (Phase 3)UnknownNCT04667143
What this trial is testing

Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy

Who this might be right for
Diabetes Mellitus, Type II
Jiangsu HengRui Medicine Co., Ltd. 760
Testing effectiveness (Phase 2)UnknownNCT03279263
What this trial is testing

An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Melior Pharmaceuticals 400
Large-scale testing (Phase 3)Study completedNCT01179048
What this trial is testing

Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 9,341
Large-scale testing (Phase 3)Study completedNCT01811485
What this trial is testing

Study of Efficacy and Safety LMF237 in Patients With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Vildagliptin Monotherapy

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 171
Not applicableStudy completedNCT06376240
What this trial is testing

The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesMicrovascular FunctionRetinopathy, Diabetic+2 more
Maastricht University Medical Center 40
Not applicableUnknownNCT03721991
What this trial is testing

GABA Treatment in Subjects With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Steno Diabetes Center Copenhagen 30
Post-approval studies (Phase 4)Study completedNCT03721874
What this trial is testing

Effects of 2 Weeks Treatment With Dapagliflozin in Subjects With an Impaired Glucose Homeostasis on Nocturnal Substrate Oxidation

Who this might be right for
Prediabetic StateSubstrate Oxidation
Maastricht University 16
Early research (Phase 1)Study completedNCT00570310
What this trial is testing

Neuropathic Pain Syndrome Patient Study (MK-0000-072)

Who this might be right for
Neuralgia, PostherpeticDiabetic NeuropathyPainful Small-Fiber Neuropathy+1 more
Merck Sharp & Dohme LLC 104
Early research (Phase 1)Study completedNCT02325206
What this trial is testing

Phase 1 Study to Explore the Safety and Pharmacokinetics of DAPAglifozin in Adolescents and Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Kinderkrankenhaus auf der Bult 36
Large-scale testing (Phase 3)Study completedNCT01261143
What this trial is testing

Randomized, Double-blind Study to Assess the Efficacy and Safety of α-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic Neuropathy

Who this might be right for
Diabetic Neuropathies
Bukwang Pharmaceutical 164
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07239440
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Who this might be right for
Diabete Mellitus
Dong-A ST Co., Ltd. 288
Large-scale testing (Phase 3)UnknownNCT05095389
What this trial is testing

Adipose Derived Regenerative Cells In the Treatment of Diabetic Foot Ulcers

Who this might be right for
Diabetic Foot Ulcer
Paracrine, INC. 290
Next Page